» Articles » PMID: 38325759

Chronic Visceral Pain: New Peripheral Mechanistic Insights and Resulting Treatments

Overview
Specialty Gastroenterology
Date 2024 Feb 7
PMID 38325759
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic visceral pain is one of the most common reasons for patients with gastrointestinal disorders, such as inflammatory bowel disease or disorders of brain-gut interaction, to seek medical attention. It represents a substantial burden to patients and is associated with anxiety, depression, reductions in quality of life, and impaired social functioning, as well as increased direct and indirect health care costs to society. Unfortunately, the diagnosis and treatment of chronic visceral pain is difficult, in part because our understanding of the underlying pathophysiologic basis is incomplete. In this review, we highlight recent advances in peripheral pain signaling and specific physiologic and pathophysiologic preclinical mechanisms that result in the sensitization of peripheral pain pathways. We focus on preclinical mechanisms that have been translated into treatment approaches and summarize the current evidence base for directing treatment toward these mechanisms of chronic visceral pain derived from clinical trials. The effective management of chronic visceral pain remains of critical importance for the quality of life of suffers. A deeper understanding of peripheral pain mechanisms is necessary and may provide the basis for novel therapeutic interventions.

Citing Articles

The properties of TREM1 and its emerging role in pain-related diseases.

Fan Z, Wang L, Sun S, Ge Z Mol Brain. 2025; 18(1):15.

PMID: 40011963 PMC: 11866596. DOI: 10.1186/s13041-025-01187-w.


Upregulation of LRRC8A in the anterior cingulate cortex mediates chronic visceral pain in adult male mice with neonatal maternal deprivation.

Lu J, Dou J, Yi Z, Lian L, Ben X, Zhang F Mol Pain. 2025; 21:17448069251324645.

PMID: 39962353 PMC: 11894642. DOI: 10.1177/17448069251324645.


Microbiota-neuroepithelial signalling across the gut-brain axis.

Ohara T, Hsiao E Nat Rev Microbiol. 2025; .

PMID: 39743581 DOI: 10.1038/s41579-024-01136-9.


Advances in the pathological mechanisms and clinical treatments of chronic visceral pain.

Li Y, Zhang F, Xu T, Weng R, Zhang H, Chen Q Mol Pain. 2024; 20:17448069241305942.

PMID: 39673493 PMC: 11645724. DOI: 10.1177/17448069241305942.


The Intersection between Tryptophan-Kynurenine Pathway Metabolites and Immune Inflammation, Hormones, and Gut Microbiota in Perinatal Depression.

Liu H, Zhu K, Yang C Actas Esp Psiquiatr. 2024; 52(5):733-740.

PMID: 39403906 PMC: 11475056. DOI: 10.62641/aep.v52i5.1748.


References
1.
Shen L, Yang X, Qian W, Hou X . The role of peripheral cannabinoid receptors type 1 in rats with visceral hypersensitivity induced by chronic restraint stress. J Neurogastroenterol Motil. 2010; 16(3):281-90. PMC: 2912121. DOI: 10.5056/jnm.2010.16.3.281. View

2.
Muller T, Rasool I, Heinz-Erian P, Mildenberger E, Hulstrunk C, Muller A . Congenital secretory diarrhoea caused by activating germline mutations in GUCY2C. Gut. 2015; 65(8):1306-13. PMC: 4975829. DOI: 10.1136/gutjnl-2015-309441. View

3.
Ruiz-Medina J, Flores J, Tasset I, Tunez I, Valverde O, Fernandez-Espejo E . Alteration of neuropathic and visceral pain in female C57BL/6J mice lacking the PPAR-α gene. Psychopharmacology (Berl). 2012; 222(3):477-88. DOI: 10.1007/s00213-012-2662-8. View

4.
Bilbao A, Spanagel R . Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications. BMC Med. 2022; 20(1):259. PMC: 9389720. DOI: 10.1186/s12916-022-02459-1. View

5.
Silos-Santiago I, Hannig G, Eutamene H, Ustinova E, Bernier S, Ge P . Gastrointestinal pain: unraveling a novel endogenous pathway through uroguanylin/guanylate cyclase-C/cGMP activation. Pain. 2013; 154(9):1820-1830. DOI: 10.1016/j.pain.2013.05.044. View